^
Association details:
| Biomarker: | ALK positive |
|---|---|
| Cancer: | Peripheral T-cell Lymphoma |
| Drug: | Alecensa (alectinib) (ALK inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Peripheral T-Cell Lymphomas...Other recommended regimens...Alectinib (ALK+ ALCL only)
